Hasil Filter

1718

Total database: 17430
Struktur (SMILES)
1183 (68.9%)
Target
1195 (69.6%)
Genomik
64 (3.7%)
Referensi
1718 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (1718)

Halaman 35 / 35
Zaleplon Approved DB00962
small molecule | CAS: 151319-34-5

Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug …

Kategori:
AcetatesAcids, AcyclicAmides +22
Target Protein:
Gamma-aminobutyric acid receptor subunit alpha-1
Waktu ParuhApproximately 1 hour
Vol. Distribusi* 1.4 L/kg
Klirens* 1 L/h/kg
Genetik -
Zaltoprofen DB06737
small molecule | CAS: 74711-43-6

A non-steroidal anti-inflammatory drug approved for use in Japan in 1993.

Kategori:
Acids, AcyclicAgents causing hyperkalemiaAgents that produce hypertension +19
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Zanapezil DB04859
small molecule | CAS: 142852-50-4

Zanapezil (TAK-147) is a selective acetylcholine (ACh) esterase inhibitor under investigation as a drug for Alzheimer's disease (AD) treatment.

Kategori:
Heterocyclic Compounds, Fused-Ring
Target Protein:
Acetylcholinesterase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Zanthoxylum clava-herculis bark is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Zanthoxylum clava-herculis whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Zanubrutinib Approved DB15035
small molecule | CAS: 1691249-45-2

Zanubrutinib is a novel Bruton's tyrosine kinase (BTK) inhibitor used for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.[L10163] Mantle cell lymphoma is an aggressive mature B-cell non-Hodgkin lym…

Kategori:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsBruton's tyrosine kinase (BTK) inhibitors +19
Target Protein:
Tyrosine-protein kinase BTKEpidermal growth factor receptorReceptor tyrosine-protein kinase erbB-2 +12
Waktu ParuhFollowing administr…
Vol. DistribusiThe geometric mean …
KlirensThe mean (%CV) appa…
Genetik -
Zavegepant Approved DB15688
small molecule | CAS: 1337918-83-8

Zavegepant (BHV-3500) is a calcitonin gene-related peptide (CGRP) receptor antagonist.[L45505] CGRP is released from sensory nerves and acts as a strong vasodilator, and thanks to these properties, it is involved in pain pathways. CGRP receptors are expressed…

Kategori:
Antimigraine PreparationsCalcitonin Gene-Related Peptide (CGRP) AntagonistsCalcitonin Gene-Related Peptide Receptor Antagonists +14
Target Protein:
Calcitonin gene-related peptide type 1 receptor
Waktu ParuhFollowing a 10 mg d…
Vol. DistribusiIntranasal zavegepa…
KlirensIntranasal zavegepa…
Genetik -
ZD4407 DB06539
small molecule | CAS: 166882-70-8

The drug ZD4407, an antiasthmatic developed by AstraZeneca, functions as a 5-lipoxygenase inhibitor. It entered Phase 1 clinical trials for chronic obstructive pulmonary disease (COPD) in the United Kingdom but was discontinued during this phase in March 2003

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
ZEN-012 DB06042
small molecule

ZEN-012 is a novel small molecule and the first anti-cancer drug in development involving two mechanisms of action: tubulin and topoisomerase II inhibition. ZEN-012 also expresses additional modes of action such as pro-apoptotic and anti-angiogenic properties…

Target Protein:
Tubulin beta chainTubulin beta-1 chainTubulin beta-3 chain +3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech | CAS: 2376463-48-6

Zilovertamab vedotin is an Antibody-drug conjugate (ADC) comprising an anti-ROR1 monoclonal antibody (UC-961), a proteolytically cleavable maleimidocaproyl-valine-citrulline-para-aminobenzoate linker (mc-vc-PAB), and a monomethyl auristatin E (MMAE) cytotoxin.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Zilpaterol DB11479
small molecule | CAS: 119520-05-7

Zilpaterol is a ?2 adrenergic agonist sold under the trade name, Zilmax, produced by Intervet, a subsidiary of Merck & Co. Zilpaterol is typically fed to cattle in the last three to six weeks of life with a brief washout period to clear the drug from the tiss…

Kategori:
Heterocyclic Compounds, Fused-RingOrganosilicon CompoundsReceptors, Adrenergic, beta
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Zolpidem Approved DB00425
small molecule | CAS: 82626-48-0

Zolpidem, also known as _Ambien_, is a hypnotic drug that was initially approved by the FDA in 1992 [FDA label]. Zolpidem improves sleep in patients with insomnia. It is aimed for use in patients with difficulties initiating sleep. This drug decreases the ti…

Kategori:
Benzodiazepine hypnotics and sedativesCentral Nervous System AgentsCentral Nervous System Depressants +21
Target Protein:
Gamma-aminobutyric acid receptor subunit alpha-1Gamma-aminobutyric acid receptor subunit gamma-3Gamma-aminobutyric acid receptor subunit alpha-2 +2
Waktu ParuhThe average zolpide…
Vol. Distribusi0.54 to 0.68 L/kg (…
KlirensIn a clinical trial…
Genetik -
Zonisamide Approved DB00909
small molecule | CAS: 68291-97-4

Zonisamide is a sulfonamide anticonvulsant used as an adjunctive therapy in adults with partial-onset seizures.[L42530,L42535] Zonisamide may act by blocking repetitive firing of voltage-gated sodium channels, leading to a reduction of T-type calcium channel…

Kategori:
Agents causing hyperkalemiaAmidesAnti-epileptic Agent +32
Target Protein:
Sodium channel protein type 1 subunit alphaSodium channel protein type 2 subunit alphaSodium channel protein type 3 subunit alpha +29
Waktu ParuhIn plasma, the elim…
Vol. DistribusiFollowing a 400 mg …
KlirensIn patients not tak…
Genetik -
Zorubicin DB11618
small molecule | CAS: 54083-22-6

Zorubicin is a drug of the anthracycline class - a class of medications that have historically demonstrated effective chemotherapy for a variety of cancer types.

Kategori:
AnthracyclinesAnthracyclines and Related SubstancesAntibiotics, Antineoplastic +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Zosuquidar DB06191
small molecule | CAS: 167354-41-8

Zosuquidar is a compound of antineoplastic drug candidates currently under development. It is now in "Phase 3" of clinical tests in the United States. Its action mechanism consists of the inhibition of P-glycoproteins; other drugs with this mechanism include …

Kategori:
BenzocycloheptenesDrug Resistance, MultipleHeterocyclic Compounds, Fused-Ring +1
Target Protein:
ATP-dependent translocase ABCB1Phosphatidylcholine translocator ABCB4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Zotarolimus DB18761
small molecule | CAS: 221877-54-9

Zotarolimus is an immunosuppressant under investigation for use in drug-eluting stents.

Kategori:
Anti-Bacterial AgentsLactonesMacrolides
Target Protein:
Serine/threonine-protein kinase mTOR
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Zotepine Approved DB09225
small molecule | CAS: 26615-21-4

Zotepine, with the formula (2-chloro-11-(2-dimethyl-amino-ethoxy)-dibenzo thiepin, is a neuroleptic drug. It was designed and synthesized by Fujisawa Pharmaceutical Co Ltd.[A31855] It has been used as an antipsychotic in Japan, India and some places in Europe…

Kategori:
Antidepressive AgentsAntipsychotic AgentsAntipsychotic Agents (Second Generation [Atypical]) +21
Target Protein:
D(1) dopamine receptorD(2) dopamine receptor5-hydroxytryptamine receptor 2A +4
Waktu ParuhThe half-life of zo…
Vol. DistribusiThe apparent volume…
KlirensThe apparent oral c…
Genetik -
Zuclopenthixol Approved DB01624
small molecule | CAS: 53772-83-1

Zuclopenthixol, also known as Zuclopentixol or Zuclopenthixolum, is an antipsychotic agent. Zuclopenthixol is a thioxanthene-based neuroleptic with therapeutic actions similar to the phenothiazine antipsychotics. It is an antagonist at D1 and D2 dopamine rece…

Kategori:
Adrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-AntagonistsAdrenergic Antagonists +34
Target Protein:
D(1A) dopamine receptorD(1B) dopamine receptorD(2) dopamine receptor +4
Waktu Paruh20 hours (range 12-…
Vol. Distribusi20 L/kg.
Klirensapproximately 0.9 L…
Genetik -
Menampilkan 1701–1718 dari 1718
Sebelumnya Halaman 35 / 35 Berikutnya